Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121992626 | 12199262 | 6 | F | 2016 | 20160729 | 20160322 | 20160809 | PER | US-PFIZER INC-2016104912 | PFIZER | 67.00 | YR | F | Y | 55.00000 | KG | 20160809 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121992626 | 12199262 | 1 | PS | SUTENT | SUNITINIB MALATE | 1 | 37.5 MG, 1X/DAY | X731C | 21938 | 37.5 | MG | CAPSULE, HARD | QD | ||||||
| 121992626 | 12199262 | 2 | C | ATIVAN | LORAZEPAM | 1 | UNK | 0 | |||||||||||
| 121992626 | 12199262 | 3 | C | LISINOPRIL. | LISINOPRIL | 1 | UNK | 0 | |||||||||||
| 121992626 | 12199262 | 4 | C | BABY ASPIRIN | ASPIRIN | 1 | UNK | 0 | |||||||||||
| 121992626 | 12199262 | 5 | C | PAROXETINE. | PAROXETINE | 1 | UNK | 0 | |||||||||||
| 121992626 | 12199262 | 6 | C | MORPHINE | MORPHINE | 1 | UNK | 0 | |||||||||||
| 121992626 | 12199262 | 7 | C | SANDOSTATIN | OCTREOTIDE ACETATE | 1 | UNK | 0 | |||||||||||
| 121992626 | 12199262 | 8 | C | PROMETHAZINE | PROMETHAZINEPROMETHAZINE HYDROCHLORIDE | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 121992626 | 12199262 | 1 | Carcinoid tumour of the gastrointestinal tract |
| 121992626 | 12199262 | 6 | Pain |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 121992626 | 12199262 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 121992626 | 12199262 | Carcinoid tumour of the gastrointestinal tract | |
| 121992626 | 12199262 | Decreased appetite | |
| 121992626 | 12199262 | Diarrhoea | |
| 121992626 | 12199262 | Disease progression | |
| 121992626 | 12199262 | Dysgeusia | |
| 121992626 | 12199262 | Dysphonia | |
| 121992626 | 12199262 | Dyspnoea | |
| 121992626 | 12199262 | Fatigue | |
| 121992626 | 12199262 | Nasal congestion | |
| 121992626 | 12199262 | Nausea | |
| 121992626 | 12199262 | Oedema peripheral | |
| 121992626 | 12199262 | Pain | |
| 121992626 | 12199262 | Product use issue | |
| 121992626 | 12199262 | Vomiting | |
| 121992626 | 12199262 | Weight decreased | |
| 121992626 | 12199262 | Wheezing |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 121992626 | 12199262 | 1 | 20160201 | 0 | ||
| 121992626 | 12199262 | 2 | 201401 | 0 | ||
| 121992626 | 12199262 | 3 | 201407 | 0 | ||
| 121992626 | 12199262 | 4 | 201312 | 0 | ||
| 121992626 | 12199262 | 5 | 201401 | 0 | ||
| 121992626 | 12199262 | 6 | 201401 | 0 | ||
| 121992626 | 12199262 | 7 | 201401 | 0 |